| Incyte Pharmaceuticals, Inc. is a leading
provider of an integrated platform of genomic technologies designed to aid in the
understanding of the molecular basis of disease. The Incyte General division develops and
markets gene discovery and expression products - including databases, genomic data
management software, microarray-based gene expression services, and related reagents -
enabling the pharmaceutical industry to identify new targets and pathways for drug
discovery and development. The Incyte Genetics division will provide databases,
bioinformatics, and services relating to sequencing and mapping the human genome and
identifying gene sequence variation, enabling the pharmaceutical industry to utilize
pharmacogenetics as an integral part of pharmaceutical discovery and development. |
